Regulations.gov document
New Animal Drugs: Enrofloxacin; Melengestrol; Meloxicam; Pradofloxacin; Tylosin
Rule · FDA-2012-N-0002 · posted Dec 31, 2012
Key facts
| Document ID | FDA-2012-N-0002-0032 |
|---|---|
| Title | New Animal Drugs: Enrofloxacin; Melengestrol; Meloxicam; Pradofloxacin; Tylosin |
| Document type | Rule |
| Subtype | Final Rule |
| Agency | FDA |
| Docket | FDA-2012-N-0002 |
| Posted | Dec 31, 2012 |
| Federal Register citation | 77 FR 76862 |
| FR document number | 2012-31397 |
| CFR | 21 CFR Parts 520, 522, 529, and 558 |
| Comment period opens | Dec 31, 2012 |
| Effective date | Dec 31, 2012 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: